Exact Sciences Corporation
36
7
11
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.9%
5 terminated/withdrawn out of 36 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
25%
5 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (36)
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Role: collaborator
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Role: lead
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Role: lead
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer
Role: lead
Informed Choice - Compass
Role: lead
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Role: lead
Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality
Role: lead
First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer
Role: lead
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
Role: lead
Falcon Real World Evidence Registry
Role: lead
The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
Role: collaborator
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
Role: collaborator
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
Role: lead
Stool Sample Collection Study
Role: collaborator
Home Usability Study of the SARS-CoV-2 (COVID-19) Test
Role: lead
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"
Role: lead
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"
Role: lead
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
Role: collaborator
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Role: lead
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01
Role: lead